A Kalamazoo company developing a new treatment for people with hypertension received another infusion of capital as it prepares for a clinical trial in Europe late this year.

Venture capital investing in Michigan had one of its best years ever in 2012, setting the stage for what one venture investor sees as “another very big year” for further growth.

Investors say once Michigan’s maturing life sciences industry can regularly generate success stories, the chances are that more venture capital will follow.

After closing fundraising on its flagship fund to invest more than $15.1 million in early stage Michigan-based businesses, a Grand Rapids venture fund can now focus on building its investment portfolio and recording its first exit.